The use of generic versus brand names in (clinical) pharmacology education across Europe: a cross-sectional survey
European Journal of Clinical Pharmacology · 2026
DOI: 10.1007/s00228-026-04005-x ↗Kurz gefasst
Querschnittstudie in der Zeitschrift European Journal of Clinical Pharmacology, 2026. Verfasst von Veronika Slezáková und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Drug Information Centre, Institutional Pharmacy, Institute for Clinical and Experimental Medicine IKEM, Prague, C…. Hauptthemen laut MEDLINE: Drugs, Generic, Pharmacology, Clinical, Terminology as Topic. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Masaryk University.
Abstract (Originalsprache)
PURPOSE: In pharmacology and clinical pharmacology (P&CP) teaching, using generic names of medicines contributes to global comprehensibility. However, brand names are often used in routine clinical practice, which may pose a challenge in the educational setting. This study aimed to explore P&CP teachers’ use of and attitudes towards generic and brand names in undergraduate education, as well as national prescription regulations. METHODS: A survey was conducted with P&CP teachers from 38 European countries. An electronic questionnaire was used to collect data on the participants’ profiles, the nomenclature used and preferred in undergraduate education, and prescribing practices. The latter were then verified with national regulatory authorities. RESULTS: Sixty-one teachers from 23 countries participated in the study, the majority being physicians (n = 47). In total, 13 (21%) teachers use only generic names in their teaching, while 46 (75%) use both generic and brand names. Thirty-four (56%) teachers preferred listing brand names in case-based teaching, as this reflects real life. Conversely, 37 (61%) teachers stated that students should not be exposed to brand names before graduation. Generic prescribing is either allowed or mandatory in all participating countries except two, where brand-name prescribing is mandatory. CONCLUSION: This study shows that generic names must remain fundamental in P&CP education, but brand names also play a role, especially in case-based education, reflecting real-life practice. Potential implications of generic and brand prescribing for internationalisation in education could be worth further attention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy and Drug Information Centre, Institutional Pharmacy, Institute for Clinical and Experimental Medicine IKEM, Prague, Czech Republic.
- Department of Applied Pharmacy, Faculty of Pharmacy, Masaryk University, Brno, Czech Republic.
- Department of Pharmacology, Faculty of Medicine, Masaryk University, Kamenice 753/5, Brno, 625 00, Czech Republic. rychlickova@med.muni.cz.
- St. Anne's University Hospital, Pekarska, 664/53, Brno, 602 00, Czech Republic. rychlickova@med.muni.cz.
- Department of Pharmacology, Montpellier University Hospital, 34090, Montpellier, France.
- Pathogenesis and Control of Chronic and Emerging Infections (PCCEI), Univ Montpellier, INSERM, Univ Antilles, 34090, Montpellier, France.
Förderung
- Masaryk University
Zitieren
APA
Slezáková, V., Rychlíčková, J., Cazaubon, Y., Donker, E. M., van Leeuwen, E., Likic, R., Mazánková, D., Piët, J. D., De Ponti, F., Raasch, W., van Rosse, F., Sanz, E. J., Schwaninger, M., van Agtmael, M. A., & Tichelaar, J. (2026). The use of generic versus brand names in (clinical) pharmacology education across Europe: a cross-sectional survey. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-026-04005-x
Vancouver
Slezáková V, Rychlíčková J, Cazaubon Y, Donker EM, van Leeuwen E, Likic R, et al. The use of generic versus brand names in (clinical) pharmacology education across Europe: a cross-sectional survey. European Journal of Clinical Pharmacology. 2026. doi:10.1007/s00228-026-04005-x
BibTeX
@article{Slezkov2026,
author = {Slezáková, Veronika and Rychlíčková, Jitka and Cazaubon, Yoann and Donker, Erik M and van Leeuwen, Ellen and Likic, Robert and Mazánková, Dana and Piët, Joost D and De Ponti, Fabrizio and Raasch, Walter and van Rosse, Floor and Sanz, Emilio J and Schwaninger, Markus and van Agtmael, Michiel A and Tichelaar, Jelle},
title = {The use of generic versus brand names in (clinical) pharmacology education across Europe: a cross-sectional survey},
journal = {European Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1007/s00228-026-04005-x}
}
EUVIMED